Shares in major drugmakers started to recover after GSK, Haleon, Sanofi and Pfizer lost a combined $39 billion in market value over the past week over litigation focused on heartburn drug Zantac https://t.co/GtNTsnYTA4 pic.twitter.com/Raex5424KE— Reuters (@Reuters) August 12, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


